Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexander Hagstotz
Observed name:
Hagstotz, Alexander
Institutions:
University Hospital Carl Gustav Carus,
Technische Universität Dresden
Observed institutions:
University Hospital Carl Gustav Carus,
Technische Universität Dresden
ORCID:
0009-0008-0756-7081
Observed ORCID:
0009-0008-0756-7081
OpenAlex ID:
A5073057580
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
2019
·
Isabell Schau
, Susanne Michen
, et al.
·
Scientific Reports
·
36
PDF
Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
2021
·
Willi Jugel
, Achim Aigner
, et al.
·
Pharmaceutics
·
22
PDF
Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas
2023
·
Dietmar Krex
, Paula Bartmann
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
2026
·
Alexander Hagstotz
, Susanne Michen
, et al.
·
Pharmacology & Therapeutics
Antibody-TLR3 agonist-conjugates program the tumor microenvironment and induce immune responses leading to tumor regression in experimental EGFRvIII-positive glioma
2026
·
Alexander Hagstotz
, Isabell Schau
, et al.
·
Biomedicine & Pharmacotherapy
PDF
Abstract LB116: Antibody-TLR3 agonist-conjugates induce innate immune responses and immune memory eradicating experimental EGFRvIII-positive tumors
2024
·
Achim Temme
, Alexander Hagstotz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
69
H-index:
3
I10-index:
3
Year
Topic
Type